HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

tremelimumab

a fully human anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for immunotherapy of metastatic melanoma
Also Known As:
CP 675; CP 675206; CP-675; CP-675,206; CP-675206; CP675 cpd; CP675206; ticilimumab
Networked: 279 relevant articles (47 outcomes, 134 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ribas, Antoni: 20 articles (01/2019 - 12/2005)
2. Gomez-Navarro, Jesus: 16 articles (02/2013 - 12/2005)
3. Maio, Michele: 11 articles (01/2021 - 10/2010)
4. Calabrò, Luana: 10 articles (01/2021 - 10/2010)
5. Kirkwood, John M: 8 articles (01/2017 - 10/2007)
6. Glaspy, John A: 8 articles (11/2015 - 12/2005)
7. Tarhini, Ahmad A: 7 articles (01/2019 - 10/2007)
8. Comin-Anduix, Begoña: 7 articles (01/2016 - 12/2005)
9. Jalil, Jason: 7 articles (01/2013 - 05/2008)
10. Danielli, Riccardo: 6 articles (02/2020 - 10/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Melanoma (Melanoma, Malignant)
3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
4. Squamous Cell Carcinoma of Head and Neck
5. Small Cell Lung Carcinoma (Small Cell Lung Cancer)

Related Drugs and Biologics

1. durvalumab
2. Ipilimumab
3. Immune Checkpoint Inhibitors
4. Monoclonal Antibodies
5. Nivolumab
6. CTLA-4 Antigen
7. Platinum
8. atezolizumab
9. B7-H1 Antigen
10. Proteins (Proteins, Gene)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Therapeutics
3. Immunotherapy
4. Precision Medicine
5. Radiotherapy